<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37270195</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>02</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Randomised, controlled, open-label pragmatic trial evaluating changes in functional exercise capacity after primary care <i>PU</i>lmonary <i>RE</i>habilitation in patients with long COVID: protocol of the PuRe-COVID trial in Belgium.</ArticleTitle><Pagination><StartPage>e071098</StartPage><MedlinePgn>e071098</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e071098</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2022-071098</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Long COVID is a prevalent condition with many multisystemic symptoms, such as fatigue, dyspnoea, muscle weakness, anxiety, depression and sleep difficulties, impacting daily life and (social and physical) functioning. Pulmonary rehabilitation (PR) may improve physical status and symptoms of patients with long COVID, yet the evidence is limited. Therefore, this trial aims to study the effect of primary care PR on exercise capacity, symptoms, physical activity and sleep in patients with long COVID.</AbstractText><AbstractText Label="METHODS AND ANALYSIS">PuRe-COVID is a prospective, pragmatic, open-label, randomised controlled trial. A sample of 134 adult patients with long COVID will be randomised to a 12 week PR programme in primary care, supervised by a physiotherapist or to a control group, following no PR. A 3 month and 6 month follow-up period is foreseen. The primary endpoint will be the change in exercise capacity measured by 6-minute walk distance (6MWD) at 12 weeks, hypothesising a more significant improvement in the PR group. Other parameters, such as pulmonary function tests (including maximal inspiratory pressure/maximal expiratory pressure), patient-reported outcomes (COPD Assessment Test, modified Medical Research Council Dyspnoea Scale, Checklist Individual Strength, post-COVID-19 Functional Status, Nijmegen questionnaire, Hospital Anxiety and Depression Scale, Work Productivity and Activity Impairment Questionnaire and EuroQol-5D-5L), physical activity measured by an activity tracker, hand grip strength and sleep efficiency, are secondary and exploratory outcomes.The recruitment started on 19 April 2022, and 52 patients were included as of 14 December 2022.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION">Ethical approval was obtained in Belgium from the relevant institutional review boards on 21 February 2022 (Antwerp University Hospital, approval number 2022-3067) and on 1 April 2022 (Ziekenhuis Oost-Limburg in Genk, approval number Z-2022-01). Findings from this randomised controlled trial will be disseminated in peer-reviewed publications and presentations at international scientific meetings.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER">NCT05244044.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Volckaerts</LastName><ForeName>Tess</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-4490-5381</Identifier><AffiliationInfo><Affiliation>Department of Rehabilitation Sciences and Physiotherapy (MOVANT), University of Antwerp, Antwerpen, Belgium tess.volckaerts@uza.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Trial Center, University Hospital Antwerp, Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vissers</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Sciences and Physiotherapy (MOVANT), University of Antwerp, Antwerpen, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burtin</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>REVAL-Rehabilitation Research Center, Faculty of Rehabilitation Sciences, BIOMED Biomedical Research Institute, Hasselt University, Hasselt, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Meerbeeck</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, University Hospital Antwerp, Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Soomer</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, University Hospital Antwerp, Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oostveen</LastName><ForeName>Ellie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, University Hospital Antwerp, Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Claes</LastName><ForeName>Kim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Clinical Trial Center, University Hospital Antwerp, Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roelant</LastName><ForeName>Ella</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Clinical Trial Center, University Hospital Antwerp, Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verhaegen</LastName><ForeName>Iris</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Clinical Trial Center, University Hospital Antwerp, Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomeer</LastName><ForeName>Michiel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Ziekenhuis Oost-Limburg, Genk, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Life Science, Hasselt University, Hasselt, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Criel</LastName><ForeName>Maarten</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Ziekenhuis Oost-Limburg, Genk, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quadflieg</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>REVAL-Rehabilitation Research Center, Faculty of Rehabilitation Sciences, BIOMED Biomedical Research Institute, Hasselt University, Hasselt, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cops</LastName><ForeName>Dries</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>REVAL-Rehabilitation Research Center, Faculty of Rehabilitation Sciences, BIOMED Biomedical Research Institute, Hasselt University, Hasselt, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruttens</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Ziekenhuis Oost-Limburg, Genk, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Life Science, Hasselt University, Hasselt, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lapperre</LastName><ForeName>Th&#xe9;r&#xe8;se S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, University Hospital Antwerp, Edegem, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerpen, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05244044</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018737" MajorTopicYN="N">Hand Strength</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001530" MajorTopicYN="N" Type="Geographic">Belgium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017079" MajorTopicYN="N">Exercise Tolerance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">medical education &amp; training</Keyword><Keyword MajorTopicYN="N">primary care</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>4</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>3</Day><Hour>20</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37270195</ArticleId><ArticleId IdType="pmc">PMC10255055</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2022-071098</ArticleId><ArticleId IdType="pii">bmjopen-2022-071098</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ballering AV, van Zon SKR, olde Hartman TC, et al. . Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. The Lancet 2022;400:452&#x2013;61. 10.1016/S0140-6736(22)01214-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE, the Scottish Intercollegiate Guidelines Network (SIGN) and the Royal College of General Practitioners (RCGP) . COVID-19 rapid guideline: managing the long-term effects of COVID-19. 2020.</Citation></Reference><Reference><Citation>Sivan M, Taylor S. NICE guideline on long Covid. BMJ 2020;371:m4938. 10.1136/bmj.m4938</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4938</ArticleId><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler DM. The costs of long COVID. JAMA Health Forum 2022;3:e221809. 10.1001/jamahealthforum.2022.1809</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2022.1809</ArticleId><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapatero DC, Hanquet G, Van den K. Epidemiology of long COVID: a pragmatic review of the literature. In: COVID 19 &#x2013; KCE Contributions. 2021.</Citation></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021;397:220&#x2013;32. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, et al. . Managing the long term effects of COVID-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ 2021;372:136. 10.1136/bmj.n136</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniou KM, Vasarmidi E, Russell A-M, et al. . European respiratory society statement on long COVID-19 follow-up. Eur Respir J 2022;60:2102174. 10.1183/13993003.02174-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02174-2021</ArticleId><ArticleId IdType="pmc">PMC9349784</ArticleId><ArticleId IdType="pubmed">35144991</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021;38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, et al. . Management of post-acute COVID-19 in primary care. BMJ 2020:m3026. 10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dowds J, O&#x2019;Brien K, et al. . Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity. Ann Am Thorac Soc 2021;18:997&#x2013;1003. 10.1513/AnnalsATS.202009-1175OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202009-1175OC</ArticleId><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, et al. . The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine 2023;55:101762. 10.1016/j.eclinm.2022.101762</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Meys R, Delbressine JM, Go&#xeb;rtz YMJ, et al. . Generic and respiratory-specific quality of life in non-hospitalized patients with COVID-19. JCM 2020;9:3993. 10.3390/jcm9123993</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9123993</ArticleId><ArticleId IdType="pmc">PMC7764406</ArticleId><ArticleId IdType="pubmed">33317214</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, et al. . Global prevalence of post-Coronavirus disease 2019 (COVID-19) condition or long COVID: A meta-analysis and systematic review. J Infect Dis 2022;226:1593&#x2013;607. 10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Spruit MA, Holland AE, Singh SJ, et al. . COVID-19: interim guidance on rehabilitation in the hospital and post-hospital phase from a European respiratory society and American Thoracic society-coordinated International task force. Eur Respir J 2020;56:2002197. 10.1183/13993003.02197-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02197-2020</ArticleId><ArticleId IdType="pmc">PMC7427118</ArticleId><ArticleId IdType="pubmed">32817258</ArticleId></ArticleIdList></Reference><Reference><Citation>Nambi G, Abdelbasset WK, Alrawaili SM, et al. . Comparative effectiveness study of low versus high-intensity aerobic training with resistance training in community-dwelling older men with post-COVID 19 Sarcopenia: A randomized controlled trial. Clin Rehabil 2022;36:59&#x2013;68. 10.1177/02692155211036956</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/02692155211036956</ArticleId><ArticleId IdType="pubmed">34344230</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Xia W, Zhan C, et al. . A Telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial. Thorax 2022;77:697&#x2013;706. 10.1136/thoraxjnl-2021-217382</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-217382</ArticleId><ArticleId IdType="pmc">PMC8318721</ArticleId><ArticleId IdType="pubmed">34312316</ArticleId></ArticleIdList></Reference><Reference><Citation>Gloeckl R, Leitl D, Jarosch I, et al. . Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study. ERJ Open Res 2021;7:00108&#x2013;2021. 10.1183/23120541.00108-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00108-2021</ArticleId><ArticleId IdType="pmc">PMC7957293</ArticleId><ArticleId IdType="pubmed">34095290</ArticleId></ArticleIdList></Reference><Reference><Citation>Nopp S, Moik F, Klok FA, et al. . Outpatient pulmonary rehabilitation in patients with long COVID improves exercise capacity, functional status, Dyspnea, fatigue, and quality of life. Respiration 2022;101:593&#x2013;601. 10.1159/000522118</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000522118</ArticleId><ArticleId IdType="pmc">PMC9059007</ArticleId><ArticleId IdType="pubmed">35203084</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannelore Dillen GB, Bastiaens A, Li A, et al. . Richtlijn &#x2018;Opvolging en Revalidatie Van Pati&#xeb;nten met Aanhoudende Klachten NA COVID-19 in de Eerste Lijn. In: volksgezondheid F, ed. Belgisch Centrum voor Evidence-Based Medicine (CEBAM). 2022.</Citation></Reference><Reference><Citation>Salman D, Vishnubala D, Le Feuvre P, et al. . Returning to physical activity after COVID-19. BMJ 2021;372:m4721. 10.1136/bmj.m4721</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4721</ArticleId><ArticleId IdType="pubmed">33419740</ArticleId></ArticleIdList></Reference><Reference><Citation>Schutte-Rodin S, Broch L, Buysse D, et al. . Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008;4:487&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2576317</ArticleId><ArticleId IdType="pubmed">18853708</ArticleId></ArticleIdList></Reference><Reference><Citation>Santus P, Tursi F, Croce G, et al. . Changes in quality of life and dyspnoea after hospitalization in COVID-19 patients discharged at home. Multidiscip Respir Med 2020;15:713. 10.4081/mrm.2020.713</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/mrm.2020.713</ArticleId><ArticleId IdType="pmc">PMC7582021</ArticleId><ArticleId IdType="pubmed">33117535</ArticleId></ArticleIdList></Reference><Reference><Citation>Daynes E, Gerlis C, Briggs-Price S, et al. . COPD assessment test for the evaluation of COVID-19 symptoms. Thorax 2021;76:185&#x2013;7. 10.1136/thoraxjnl-2020-215916</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215916</ArticleId><ArticleId IdType="pubmed">33148809</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Herck M, Go&#xeb;rtz YMJ, Houben-Wilke S, et al. . Severe fatigue in long COVID: web-based quantitative follow-up study in members of Online long COVID support groups. J Med Internet Res 2021;23:e30274. 10.2196/30274</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/30274</ArticleId><ArticleId IdType="pmc">PMC8457337</ArticleId><ArticleId IdType="pubmed">34494964</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon GJAM, Barco S, et al. . The post-COVID-19 functional status scale: a tool to measure functional status over time after COVID-19. Eur Respir J 2020;56:2001494. 10.1183/13993003.01494-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Snaith RP. Health and quality of life outcomes 2003;1:29. Health Qual Life Outcomes 2003;1:29. 10.1186/1477-7525-1-29</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-1-29</ArticleId><ArticleId IdType="pmc">PMC183845</ArticleId><ArticleId IdType="pubmed">12914662</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993;4:353&#x2013;65. 10.2165/00019053-199304050-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00019053-199304050-00006</ArticleId><ArticleId IdType="pubmed">10146874</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen MF, Bonsel GJ, Luo N. Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value SETS from seven countries. PharmacoEconomics 2018;36:675&#x2013;97. 10.1007/s40273-018-0623-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-018-0623-8</ArticleId><ArticleId IdType="pmc">PMC5954015</ArticleId><ArticleId IdType="pubmed">29470821</ArticleId></ArticleIdList></Reference><Reference><Citation>Holland AE, Spruit MA, Troosters T, et al. . An official European respiratory society/American Thoracic society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014;44:1428&#x2013;46. 10.1183/09031936.00150314</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00150314</ArticleId><ArticleId IdType="pubmed">25359355</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki JE, John D, Freedson PS. Validation and comparison of Actigraph activity monitors. J Sci Med Sport 2011;14:411&#x2013;6. 10.1016/j.jsams.2011.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsams.2011.04.003</ArticleId><ArticleId IdType="pubmed">21616714</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovich RA, Louvaris Z, Raste Y, et al. . Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J 2013;42:1205&#x2013;15. 10.1183/09031936.00134312</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00134312</ArticleId><ArticleId IdType="pubmed">23397303</ArticleId></ArticleIdList></Reference><Reference><Citation>Cambach W, Chadwick-Straver RV, Wagenaar RC, et al. . The effects of a community-based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial. Eur Respir J 1997;10:104&#x2013;13. 10.1183/09031936.97.10010104</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.97.10010104</ArticleId><ArticleId IdType="pubmed">9032501</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer MJ, Scharloo M, Abbink JJ, et al. . Drop-out and attendance in pulmonary rehabilitation: the role of clinical and Psychosocial variables. Respiratory Medicine 2009;103:1564&#x2013;71. 10.1016/j.rmed.2008.11.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2008.11.020</ArticleId><ArticleId IdType="pubmed">19481919</ArticleId></ArticleIdList></Reference><Reference><Citation>Smid DE, Franssen FME, Houben-Wilke S, et al. . Responsiveness and MCID estimates for CAT, CCQ, and HADS in patients with COPD undergoing pulmonary rehabilitation: A prospective analysis. J Am Med Dir Assoc 2017;18:53&#x2013;8. 10.1016/j.jamda.2016.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2016.08.002</ArticleId><ArticleId IdType="pubmed">27624705</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan CM, Longworth L, Lord J, et al. . The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference. Thorax 2016;71:493&#x2013;500. 10.1136/thoraxjnl-2015-207782</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2015-207782</ArticleId><ArticleId IdType="pmc">PMC4893131</ArticleId><ArticleId IdType="pubmed">27030578</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebelo P, Oliveira A, Andrade L, et al. . Minimal clinically important differences for patient-reported outcome measures of fatigue in patients with COPD following pulmonary rehabilitation. Chest 2020;158:550&#x2013;61. 10.1016/j.chest.2020.02.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.02.045</ArticleId><ArticleId IdType="pubmed">32184112</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohannon RW, Crouch R. Minimal clinically important difference for change in 6-minute walk test distance of adults with pathology: a systematic review. J Eval Clin Pract 2017;23:377&#x2013;81. 10.1111/jep.12629</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jep.12629</ArticleId><ArticleId IdType="pubmed">27592691</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>